BioNexus Gene Lab Corporation (BGLC) - Future Price to Earnings
The recruitment of leading biochemists strengthens the position of BioNexus Gene Lab Corp. (BGLC), and the issuer's expected P/E shown on this GURU.Markets chart confirms this, as the latest parameter stands at 0.00. The business relies on Malaysian laboratories and regional logistics while adhering to standard environmental regulations regarding test disposal and office energy efficiency.
Analytical breakdowns and data insights for company BioNexus Gene Lab Corporation (BGLC)
- current price and projected stock value:
- market capitalization indicators:
- balance sheet equity data:
- debt burden and liquidity indicators:
Total Debt to Capital BioNexus Gene Lab Corp.|BGLC - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity BioNexus Gene Lab Corp.|BGLC - Company Cumulative Debt|Debt to Book Capitalization Ratio BioNexus Gene Lab Corp|BGLC - Company Long-Term Indebtedness|Company Short-Term Debts BioNexus Gene Lab|Quick Liquidity Indicator bionexusgenelab.com
- financial results and valuation multiples details:
BGLC - Company Profit|Future Profit BioNexus Gene Lab Corp.|BGLC - P/E Multiple|Future Price to Earnings BioNexus Gene Lab Corp.|BGLC - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio BioNexus Gene Lab Corp|BGLC - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) BioNexus Gene Lab|BGLC - Net earnings per share for the trailing year|Quarterly EPS earnings growth bionexusgenelab.com|BGLC - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year BioNexus Gene Lab Corp.
Analysis of all company metrics:BGLC BioNexus Gene Lab
For a fundamental asset valuation, it is critical to understand the value of future earnings as measured by the forward multiple, which correlates the current share price with the business's expected income. By analyzing the current forward P/E ratio of BioNexus Gene Lab Corp. (BGLC), an investor can determine the extent of the company's overvaluation, where a high valuation may be justified by exclusive PCR diagnostic patents that create a defensive barrier against competitors.
Who BioNexus Gene Lab Corp. competes with
Projected Price to Earnings LIN (Linde)|Market Cap to Future Earnings Ratio APD|Future Price to Earnings E. I. du Pont de Nemours and Company DD|Future Price to Earnings Multiple IP|PPG: Projected Price to Earnings|Projected Price to Earnings Ratio dow.com|LYB: Forward P/E Multiple|IFF (International Flavors & Fragrances Inc.) - Future Price to Earnings|RPM (RPM Corp) - Forward P/E Multiple|Entegris Corporation (ENTG) - Market Cap to Projected Earnings|Future Price to Earnings Suzano S.A. (SUZ)|WLK - Projected Price to Earnings Ratio|Future Price to Earnings Albemarle Corporation ALB|ICL: Price to Future Earnings Ratio|Afton Chemical - Forward P/E Multiple|Projected Price to Earnings Ratio Eastman Kodak Chemical|AXTA (Axalta Coating Systems) - Projected Price to Earnings|Price to Future Earnings Ratio ESI|Projected Price to Earnings SQM|Forward P/E Multiple Celanese Corp|Future Price to Earnings Sensient Corp (SXT)|Market Cap to Projected Earnings Cabot Chemicals|Hawkins, Inc. - Projected Price to Earnings|Future Price to Earnings Multiple AVNT|H.B. Fuller - Forward P/E Multiple|Forward Price to Earnings Multiple Methanex Corp (MEOH)|WDFC: Forward P/E Multiple|Projected Price to Earnings Ratio Chemours Co. (CC)|Future Price to Earnings Quaker Chemical|Price to Future Earnings Ratio PCT (purecycletech.com)|Forward P/E Multiple ASH|NGVT - Projected Price to Earnings Ratio|Innospec Corp - Projected Price to Earnings|Future Price to Earnings Multiple MTX|DQ - Future Price to Earnings|SLVM: Future Price to Earnings|HUN: Forward P/E Multiple|Albany International Corp (AIN) - Forward P/E Multiple|CLMT (Calumet Specialty) - Forward P/E Multiple|Future Price to Earnings ROG|Projected Price to Earnings SCL (Stepan Company)|ECVT (ecovyst.com) - Future Price to Earnings Multiple|Forward P/E Multiple NEO (NeoGenomics)|REX - Projected Price to Earnings|ASPI - Future Price to Earnings|Projected Price to Earnings Ratio Tronox Corp|Ferroglobe PLC (GSM) - Future Price to Earnings|wlkpartners.com - Future Price to Earnings Multiple|Future Price to Earnings Compass Minerals International|Kronos Worldwide Inc - Price to Expected Earnings Ratio|Projected Price to Earnings MATV (Mativ Corp)|Market Cap to Projected Earnings LSB Chemical|Forward P/E Multiple BAK (Braskem S.A.)|koppers.com - Future Price to Earnings|AdvanSix - Forward P/E Multiple|Forward Price to Earnings Multiple Orion Engineered Carbons (OEC)|rayonieram.com (RYAM) - Future Price to Earnings|ADUR (Aduro Clean Technologies Corp) - Future Price to Earnings|MAGN (Magnera Corp) - Forward P/E Multiple|Projected Price to Earnings clearwaterpaper.com (CLW)|Forward P/E Multiple TG|Projected Price to Earnings Core Molding Technologies Inc. CMT|Forward P/E Multiple FF (FutureFuel Corporation)|Future Price to Earnings Multiple FSI|Pacific Ethanol - Forward P/E Multiple|Projected Price to Earnings Ratio 5E Advanced Materials|trinseo.com (TSE) - Future Price to Earnings|Projected Price to Earnings Origin Materials|NTIC (Northern Technologies International Corp.) - Forward P/E Multiple|LanzaTech Corp (LNZA) - Market Cap to Projected Earnings|Future Price to Earnings J-Star Holding Co Ltd (YMAT)|Market Cap to Projected Earnings newerahelium.com|Bolt Projects - Projected Price to Earnings|Market Cap to Future Earnings Ratio GURE (Gulf Resources Inc.)|CNEY - Future Price to Earnings|Future Price to Earnings Multiple ALTM (Arcadium Lithium plc)|DNMR (Danimer Scientific) - Projected Price to Earnings|Projected Price to Earnings Ratio Glatfelter (GLT)|GRFX (Graphex Group Ltd) - Forward P/E Multiple|Future Price to Earnings SLCA|Forward P/E Multiple IZTC
